Bafna Pharma. (BAFNAPH)

FAST GROWER

Score breakdown: P/E: 1/3 · ROCE: 0/2 · Growth: 2/2 · Dividend: 0/1

Key Financials

Current Price₹139
Market Cap₹251.11 Cr
P/E Ratio21.93
ROCE8.34%
ROE11.68%
Dividend Yield0%
Profit Growth91.67%
Debt/Equity0.36
Sales Growth15.37%
Promoter Holding75%
52-Week Range₹72.01 — ₹202.06
SectorPharmaceuticals & Biotechnology
Book Value₹34.12

Bafna Pharma. trades with a P/E ratio of 21.93, ROCE of 8.34%, ROE of 11.68%, profit growth of 91.67%, debt-to-equity of 0.36.

Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer